FDA
-
-
-
-
-
-
-
Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC
-
-
328,604 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

